LYZ905F

Lysander-Patient Capital
Equity Fund
Series F

Series
Key Documents
Fund Profile
Fund Facts
Prospectus
Lysander Funds Ltd.

Overview

  • Asset Class
    Equity
  • CIFSC Category
    Global Equity
  • Risk Rating
    Medium
  • Number of Securities
    16

NAV

  • CAD $ NAV
    12.96
  • Change NAV $
    -0.01
  • Change NAV %
    -0.09
  • Date
    2025-05-23

Objectives

The Fund’s objective is to provide long-term capital growth by investing primarily in equity securities anywhere in the world.

Investment Focus

A global equity fund that invests in a diversified portfolio consisting primarily of global equity securities.

Fund Facts

April 30, 2025
Inception Date December 30, 2014
Currency CAD
Fund AUM $15.8 Million
NAVPU $12.67
Management Fee 0.80%
MER as of December 31, 2024 1.00%
Minimum Initial Investment $500
Minimum Subsequent Investment $100
Liquidity Daily
RSP Eligible Yes
▲ The NAVs posted are post-distribution

Portfolio Characteristics

Number of Securities 16
Dividend Yield (%) 5.0%

Portfolio

Top 10 Holdings

Security % of Fund
Canada T-Bill Due June 4/25 33.7%
Cdn. Utilities Ltd. 6.7%
BCE Inc. 6.5%
Bank of Nova Scotia 6.5%
Honda Motor Co. Ltd. ADR 5.6%
Toronto Dominion Bank 5.5%
Firm Capital Property Trust 5.5%
Verizon Communications Inc. 5.4%
Bank of Montreal 5.1%
Canadian Imperial Bank of Commerce 4.7%
Total 85.2%

Geographic Breakdown

Canada 88.6%
USA 5.5%
Other 5.3%

Performance

Inception Date

December 30, 2014

As of Date

April 30, 2025

Compound Returns

1 Month 3 Months YTD 1 Year 3 Year
(Annualized)		 5 Year
(Annualized)		 10 Year
(Annualized)		 Since Inception
(Annualized)
0.9% 0.5% 1.4% 7.0% 5.4% 11.0% 6.1% 6.1%

Calendar Year Returns

Distributions

Distributions

Distribution Frequency Quarterly
Most Recent Distribution per Unit $0.1214
12-Month Trailing Distribution Yield 4.4%
Next Record Date June 19, 2025
Next Distribution Date June 20, 2025

Quarterly Distributions

Record Date Distribution Date
March 20, 2025 March 21, 2025
June 19, 2025 June 20, 2025
September 18, 2025 September 19, 2025
December 18, 2025 December 19, 2025
Lysander Funds 2024 Final Distribution December 15, 2024
Distributions ($)/Unit2 YTD* 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Total Distributions 0.1214 0.5528 0.5874 0.1568 3.6920 0.2820 0.8276 0.1962 0.1581 0.1829 0.1186
Interest - 0.0771 0.1271 0.0347 - - - - - - -
Dividends - 0.4043 0.2994 0.1221 0.2694 0.2820 0.2308 0.1643 0.1581 0.1829 0.1186
Capital Gains - 0.0779 0.1674 - 3.4226 - 0.5968 0.0319 - - -
Withholding Tax - (0.0065) (0.0065) - - - - - - - -
*The final tax character will be determined based on the Fund’s tax year end information.

Resources

Lysander Funds Limited is the investment fund manager of Lysander-Patient Capital Equity Fund (the “Fund”). This document is not an invitation to invest in the Fund and does not constitute a public offering of sale. Purchases in the Fund can only be made through an Investment Professional on the terms in the Fund’s offering document by eligible investors. Each purchaser of units in a fund may have statutory or contractual right of action. Please read the prospectus before investing. Commissions, trailing commissions, management fees and expenses all may be associated with investment funds.

The indicated rates of return are historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Investment funds are not guaranteed or insured, their values change frequently and past performance may not be repeated.

1TSX © Copyright 2025 TSX Inc. All Rights Reserved.

2Distributions are based on the actual number of units outstanding at the relevant time. Distributions are paid in cash or reinvested in additional units. If the series’ net income/capital gains is less than the amounts distributed in the year, the distribution will include a return of capital. In these circumstances, if an investor elects to receive their distributions in cash and not reinvest distributions, it is expected that the value of their investment will decline over time. Distributions are not an indication of performance, rate of return or yield.

On November 1, 2021, the portfolio manager of the fund changed from 18 Asset Management Inc. to Patient Capital Management Inc. and the investment objective of the fund no longer had a Canadian equity securities focus. These changes could have affected the performance of the fund had these changes been in effect throughout the performance measurement period.

Effective January 1, 2020, the management fee for Series A changed from 2.00% to 1.80% and Series F changed from 1.00% to 0.80%. This change could have affected the performance of the Fund had this change been in effect throughout the performance measurement period.

®Lysander Funds is a registered trademark of Lysander Funds Limited.